Triethylamine → N-{[5-(Methoxymethyl)-1,2,4-oxadiazol-3-yl]methyl}formamide

HRID 2351312Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2351312
[CH:1]1([C:4]2[O:8][N:7]=[C:6]([CH2:9][N+:10]#[C-:11])[N:5]=2)CC1.C1([C:15]2[O:19]N(C)C(NC=O)N=2)CC1.C(N(CC)CC)C.[O:31]=P(Cl)(Cl)Cl>C(Cl)Cl.O>[CH:11]([NH:10][CH2:9][C:6]1[N:5]=[C:4]([CH2:1][O:19][CH3:15])[O:8][N:7]=1)=[O:31]

Komponenten

7

Edukt 4

HCID 8471TriethylamineHCID 24813Phosphorus oxychlorideHCID 107493421,2,4-Oxadiazole, 5-cyclopropyl-3-(isocyanomethyl)-HCID 867411005-Cyclopropyl-3-formylamino-methyl1,2,4-oxadiazole

Produkt 1

HCID 14460545N-{[5-(Methoxymethyl)-1,2,4-oxadiazol-3-yl]methyl}formamide

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 962WaterLösungsmittelHCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

5-Cyclopropyl-3-isocyanomethyl-1,2,4-oxadiazole A stirred solution of 5-cyclopropyl-3-formylamino-methyl-1,2,4-oxadiazole (60 mmol) and triethylamine (176 mmol) in CH2Cl2 (100 ml) was charged dropwise with POCl3 (60 mmol) at 0° C. The mixture was then left for 30 minutes with stirring at 0° C., whereafter a solution of Na (60 mmol) in H2O (50 ml) was added. The mixture was heated to room temperature, evaporated in vacuo. The residue was treated with ether, decanted and the solution was evaporated to give the title compound as an oil. The oil was processed without any further purification. The compound was characterized by its IR absorbtion band at 2160 cm-1.

Aufarbeitung

  1. additionwas added
  2. customevaporated in vacuo
  3. additionThe residue was treated with ether
  4. customdecanted
  5. customthe solution was evaporated

Quellen und Nachweise

ORD-Eintrag
ord-19957d3343934eab8021677ad444dc5c
Quelldatensatz
uspto-grants-1989_10
Patentnummer
US04873244

Notizen zur Reaktion

Wird geladen…